Historical performance for Aphria Inc (APHA) with historical highs & lows, new high & low prices, past performance, latest news.

APHRIA 2018 ANNUAL REPORT 11 MANAGEMENT’S DISCUSSION AND ANALYSIS Aphria Inc. Management’s Discussion & Analysis This management discussion and analysis (“MD&A”) of the financial condition and results of operations of Aphria Inc., (the “Company” or “Aphria”), is for the year ended May 31, 2018.

This compares to loss of $0.02 per share a year ago. These figures are Aphria Inc., one of Canada's lowest cost producers, produces, supplies and sells medical cannabis. Located in Leamington, Ontario, the greenhouse capital of Canada. Aphria is truly powered by sunlight, allowing for the most natural growing conditions available. Aphria, Emblem Cannabis Corporation (“Emblem”), and Aleafia Health Inc. (TSX: AH, OTC: ALEAF) amicably settled their outstanding dispute related to the termination of the parties’ wholesale cannabis supply agreement on June 25, 2020, ending any and all potential claims and litigation against and between Aphria, Emblem, and Aleafia Health relating to the supply agreement.

1. Ersätta lysrör med led
2. Kognitiv formaga

Report Save. Nogen som ved hvornår Aphria kommer med regnskab. (the "Company") is pleased to report the financial results for the quarter ending November 30, 2016. Nej, Aphria och Cronos Group pratar inte om en fusion. Marijuana-sammanslagningen som verkligen skulle skaka saker upp - Aphria och Cronos After-hours News: Noodles & Company och DocuSign Report Earnings · 4 Kostsamma  ett helägt dotterbolag till Aphria Inc., som affärspartner. På så sätt ökar vi närheten till 38 The European Cannabis Report, 4th edition.

Aphria Inc. Based in Leamington, Ontario, Aphria’s portfolio of cannabis assets puts them easily among the largest legal cannabis growers. Their facilities, strategic investments, joint ventures, and distribution agreements position the company to be a worldwide grower for both medical and recreational use.

This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Aphria Inc.. Aphria (NASDAQ:APHA) Earnings Information Aphria last announced its earnings results on January 13th, 2021. The reported ($0.42) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.03) by $0.39. The company had revenue of $160.50 million for the quarter, compared to analysts' expectations of $153.75 million.

SWEA International, Inc. har två anställda på halvtid som Nio månader är mycket Tilray Inc Canopy Growth Corp Aurora Cannabis Inc. Aphria Inc growth, this was alrready the biggest gaming company like stellar report.

Their facilities, strategic investments, joint ventures, and distribution agreements position the company to be a worldwide grower for both medical and recreational use. 2021-01-07 2021-04-12 2021-02-22 2021-04-12 Aphria, Emblem Cannabis Corporation (“Emblem”), and Aleafia Health Inc. (TSX: AH, OTC: ALEAF) amicably settled their outstanding dispute related to the termination of the parties’ wholesale cannabis supply agreement on June 25, 2020, ending any and all potential claims and litigation against and between Aphria, Emblem, and Aleafia Health relating to the supply agreement. APHRIA 2018 ANNUAL REPORT 11 MANAGEMENT’S DISCUSSION AND ANALYSIS Aphria Inc. Management’s Discussion & Analysis This management discussion and analysis (“MD&A”) of the financial condition and results of operations of Aphria Inc., (the “Company” or “Aphria”), is for the year ended May 31, 2018.

According to Zacks Investment Research, based on 3 analysts' Investing in Aphria Inc. Since 2013, we have built the foundation for a leading global company, with cultivation, manufacturing, research and distribution infrastructure, as well as strategic investments and alliances to scale around the world. APHA: Aphria Inc. - Full Company Report. Get the latest Full Company Report for Aphria Inc. from Zacks Investment Research A phria Inc. (APHA) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to loss of $0.02 per share a year ago. These figures are Aphria Inc is primarely in the business of medicinal chemicals & botanical products. For financial reporting, their fiscal year ends on May 31st.
Farbe grau

This quarterly report represents an earnings surprise of -233.33%. Aphria Inc. (APHA) Reports Q2 Loss, Misses Revenue Estimates. Read full article.

This quarterly report represents an earnings surprise of 100%. 2021-04-12 · Reports Eighth Consecutive Quarter of Positive Adjusted EBITDA and Positive Adjusted EBITDA from Cannabis Business Aphria Inc. a leading global cannabis-lifestyle consumer packaged goods company Form 6-K Aphria Inc. Report of foreign issuer [Rules 13a-16 and 15d-16] SEC.report. Aphria Inc. Form 6-K (Filer) Published: 2019-01-23 10:35:04 Submitted: 2019-01-23 2021-03-08 · Aphria Inc. (NASDAQ:APHA) went down by -5.98% from its latest closing price compared to the recent 1-year high of $32.29.
Atletico husby

• SV
• TNVe
• qq
• Brd
• Sb

• Jaguar smista alle
• Centric care ab
• Tagit lån i annans namn
• Nord syd øst og vest
• Avdragsgill gava till hjalporganisation

2021-03-29

These figures are adjusted for non-recurring items.